Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.
This case report details a relapse with malignant transformation after the completion of bleomycin, etoposide and cisplatin chemotherapy for primary mediastinal seminoma, although the residual mass after chemotherapy was <3 cm in size and did not display an increased uptake of fluorodeoxyglucose when examined using positron emission tomography.
Iwasa
Satoru
S
Division of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ando
Masashi
M
Ono
Makiko
M
Hirata
Taizo
T
Yunokawa
Mayu
M
Nakano
Eriko
E
Yonemori
Kan
K
Kouno
Tsutomu
T
Shimizu
Chikako
C
Tamura
Kenji
K
Katsumata
Noriyuki
N
Fujiwara
Yasuhiro
Y
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008479:Mediastinal Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000737:chemistry / Q000175:diagnosis / Q000209:etiology*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D018239:Seminoma / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin